$MOBI

Mobia Medical, Inc.

Insider trades
0
1
0

No SEC Form 4 filings for $MOBI in the last 30 days.

See all $MOBI insider activity →
Low

Mobia Medical, Inc. (MOBI): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Mobia Medical, Inc. (MOBI) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. 8-K false 0001489993 0001489993 2026-07-30 2026-07-30 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30,

Mobia Medical Appoints Reza Zadno, Ph.D., to its Board of Directors

Mobia Medical, Inc. (Nasdaq: MOBI) said it appointed Reza Zadno, Ph.D., as an independent director effective July 14, 2026. Zadno will also sit on the Compensation Committee. The company cited his experience leading public medical technology firms through IPOs and commercial expansion, including roles at PROCEPT BioRobotics and Avedro.

Mobia Medical, Inc. (MOBI): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Mobia Medical, Inc. (MOBI) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. 8-K 0001489993 false 0001489993 2026-07-14 2026-07-14 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 14,

MOBI sentiment & insider activity

Over the past 7 days, alphai's AI scored 1 news story mentioning MOBI (Mobia Medical, Inc.). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.

Recent MOBI coverage spans insider activity, corporate actions and financial news.

What's driving MOBI

  • Board expansion and a new independent director appointment is unlikely to drive near-term fundamentals, but it can modestly affect governance sentiment.

    SEC EDGAR 8-K · Aug 3, 2026

  • Board/compensation committee change may modestly affect governance and executive pay oversight, but it is not a direct operational or financial catalyst.

    manilatimes.net · Jul 15, 2026

  • Board and Compensation Committee composition changes are typically low-to-moderate signal for governance and oversight, with limited direct operational impact.

    SEC EDGAR 8-K · Jul 15, 2026

  • The Neurology publication strengthens clinical durability evidence for Vivistim Paired VNS Therapy, which can support adoption and future commercial/coverage momentum.

    manilatimes.net · Jul 14, 2026

  • Proposed CMS OPPS assignment continuity should reduce reimbursement uncertainty for hospitals planning to expand Vivistim programs in 2027.

    manilatimes.net · Jul 2, 2026

alphai scores every news story that mentions MOBI with an AI model for sentiment and relevance, and aggregates insider trades from Mobia Medical, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $MOBI

Score

Mobia Medical, Inc. (MOBI): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Mobia Medical, Inc. (MOBI) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. 8-K false 0001489993 0001489993 2026-07-30 2026-07-30 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30,

Mobia Medical Appoints Reza Zadno, Ph.D., to its Board of Directors

Mobia Medical, Inc. (Nasdaq: MOBI) said it appointed Reza Zadno, Ph.D., as an independent director effective July 14, 2026. Zadno will also sit on the Compensation Committee. The company cited his experience leading public medical technology firms through IPOs and commercial expansion, including roles at PROCEPT BioRobotics and Avedro.

$MOBILow

Mobia Medical, Inc. (MOBI): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Mobia Medical, Inc. (MOBI) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. 8-K 0001489993 false 0001489993 2026-07-14 2026-07-14 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 14,

$MOBIMedAI 8/10

Mobia Medical Announces Publication of Two-Year Data from VNS-REHAB Trial Demonstrating Durable and Continued Stroke Recovery with Vivistim® Paired VNS™ Therapy

Mobia Medical (Nasdaq: MOBI) said Neurology published two-year follow-up results from its VNS-REHAB trial of Vivistim Paired VNS Therapy in chronic ischemic stroke. Among 49 participants, 76% met response on FMA-UE and/or WMFT, with average gains of +7.5 FMA-UE and +0.63 WMFT. Mobia reported improvements in daily living and quality of life sustained for at least two years.

Related tickers